Screening of immigrants in the UK for latent tuberculosis

Expert Review of Respiratory Medicine

Volumn 5, Issue 4, 2011, Pages 483-486

  McNerney, Ruth ^a   Ferrara, Giovanni ^b,d   O'Grady, Justin ^d   Maeurer, Markus ^d   Zumla, Alimuddin ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF PERUGIA   (Italy)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

cost effectiveness; IFN g release assay; latent tuberculosis; screening; tuberculosis

Indexed keywords

GAMMA INTERFERON;

ARTICLE; CHINA; CLASSIFICATION ALGORITHM; CLINICAL ASSESSMENT; COST EFFECTIVENESS ANALYSIS; CYTOKINE RELEASE; GROUPS BY AGE; HEALTH CARE COST; HUMAN; IMMIGRANT; IMMUNOASSAY; INDIA; LATENT TUBERCULOSIS; PAKISTAN; PRACTICE GUIDELINE; PUBLIC HEALTH PROBLEM; SCREENING; SCREENING TEST; SOUTH AFRICA; TUBERCULOSIS CONTROL; UNITED KINGDOM;

EID: 80052623343     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.11.45     Document Type: Article

References (6)

1. Pareek M, Watson JP, Ormerod LP et al. Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis. Lancet Inf. Dis. 11(6), 435-444 (2011).
2. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann. Intern. Med. 149(3), 177-184 (2008).
3. Smith R, Cattamanchi A, Steingart KR et al. Interferon-g release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders. Curr. Opin. Rheumatol. 23(4), 377-384 (2011).
4. Pareek M, Abubakar I, White PJ, Garnett GP, Lalvani A. Tuberculosis screening of migrants to low-burden nations: insights from evaluation of UK practice. Eur. Respir. J. 37(5), 1175-1182 (2011).
5. Pooran A, Booth H, Miller RF et al. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm. Med. 10, 7 (2010).
6. McNerney R, Daley P. Towards a point-of-care test for active tuberculosis: obstacles and opportunities. Nat. Rev. Microbiol. 9(3), 204-213 (2011).